SSX Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of SSX Antibodies for advanced research in cancer biology and immunology. SSX Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SSX proteins function as cancer/testis antigens, expressed primarily in germ cells and specific tumors, serving as significant markers for cancer diagnosis and treatment. SSX protein expression has been detected in various malignancies, including melanoma and testicular cancer, highlighting potential applications in immunotherapy. Research focused on SSX proteins in tumorigenesis continues to reveal important insights into cancer progression mechanisms. Investigating SSX protein expression patterns helps identify novel therapeutic targets and biomarkers. Understanding SSX protein regulation may lead to improved cancer detection methods and treatment strategies. The extensive selection of monoclonal SSX Antibodies from Santa Cruz Biotechnology enables researchers worldwide to advance cancer research and develop innovative therapeutic approaches.